Record History
Added on September 22, 2017 at 1:19 PM by Kimber, Jessica
Modified on September 25, 2017 at 10:21 AM by Kimber, Jessica
Shared with (contributions)
DRTC: Clinical Trials Master

Type 2 Diabetes Insulin Study

The purpose of this study is to evaluate the efficacy of U-500 insulin in patients with Type 2 Diabetes.


To qualify to participate:

  • 18 to 85 years of age

  • Diagnosed with Type 2 Diabetes

  • Body mass index ≥25 but ≤50 kilograms per meter squared

  • Have a history of stable body weight

  • Concomitant antihyperglycemic agent (AHA) therapy may include metformin (MET), dipeptidyl peptidase-4 inhibitors and/or pioglitazone


How to Participate

To participate, contact Dianne Davis at (615) 936-1140 or e-mail at dianne.davis@vanderbilt.edu.